<DOC>
	<DOCNO>NCT00313911</DOCNO>
	<brief_summary>To demonstrate DTaP-IPV-HB-PRP~T combined vaccine induce high incidence rate high fever Tritanrix-HepB/Hib™ Oral Polio Vaccine ( OPV ) three vaccination 2 , 4 , 6 month age subject . To evaluate overall safety term : Any solicited adverse reaction first 7 day injection , Any adverse event reaction first 30 day injection , Any serious adverse event trial . Immunogenicity : To document immune response Hepatitis B antigen three batch investigational DTaP-IPV-HB-PRP~T vaccine .</brief_summary>
	<brief_title>Safety DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared Tritanrix-HepB/Hib™ OPV Given Age 2 , 4 , 6 Months .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>2 month old infant day inclusion Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg Informed consent form sign one parent legally acceptable representative 1 2 independent witness Able attend schedule visit comply trial procedure Has comply national immunization calendar ( BCG country ) first 2 month life . Participation another clinical trial 4 week precede first trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy Subjects congenital acquire immunodeficiency child 's surround Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness stage could interfere trial conduct completion Blood bloodderived product receive since birth Any vaccination 4 week precede first trial vaccination Vaccination plan 4 week follow trial vaccination Documented history pertussis , tetanus , diphtheria , poliomyelitis , Haemophilus influenzae type b hepatitis B infection ( ) ( confirm either clinically , serologically microbiologically ) Mother know seropositive HIV Hepatitis C , know carrier Hepatitis B surface antigen Previous vaccination pertussis , tetanus , diphtheria , poliomyelitis , Haemophilus influenzae type b infection ( ) Coagulopathy , thrombocytopenia bleed disorder contraindicate IM vaccination History seizures Febrile acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Days</minimum_age>
	<maximum_age>71 Days</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Recombinant Hepatitis B</keyword>
	<keyword>Poliomyelitis</keyword>
	<keyword>Haemophilus influenzae type b</keyword>
	<keyword>Tetanus protein</keyword>
</DOC>